Loading…
Genenta Science S.p.A. is projected to rise to $1.57 by 2027, a +5% move from its current price of $1.49. GNTA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.39 | $1.49 | $1.60 | -0.06% |
| Aug 6 | $1.35 | $1.49 | $1.64 | -0.12% |
| Aug 7 | $1.32 | $1.49 | $1.68 | -0.18% |
| Aug 8 | $1.29 | $1.49 | $1.71 | -0.24% |
| Aug 9 | $1.27 | $1.49 | $1.73 | -0.30% |
| Aug 10 | $1.25 | $1.48 | $1.76 | -0.36% |
| Aug 11 | $1.24 | $1.48 | $1.78 | -0.43% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.24 | $1.48 | $1.78 | -0.43% |
| Week 2 | $1.14 | $1.48 | $1.91 | -0.85% |
| Week 3 | $1.07 | $1.47 | $2.02 | -1.27% |
| Week 4 | $1.02 | $1.46 | $2.11 | -1.69% |
| Week 5 | $0.9691 | $1.46 | $2.20 | -2.11% |
| Week 6 | $0.928 | $1.45 | $2.27 | -2.53% |
| Week 7 | $0.8915 | $1.45 | $2.35 | -2.94% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Genenta Science S.p.A. is a clinical-stage biotechnology company focused on hematopoietic stem cell gene therapies for solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter, and it is developing Temferon for use in other solid tumor indications.
In addition, Genenta Science S.p.A. develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A.
was incorporated in 2014 and is headquartered in Milan, Italy.
Genenta Science S.p.A. GNTA trades at $1.51 per share and has a market capitalization of $72.81M, ranking 4108. The stock’s near-term outlook is reflected in the 2026 forecast, which shows an average price of $1.51 with a range from $0.58 to $1.84 and a neutral sentiment.
From 2031 onward, the forecast shifts to a bullish stance with higher expected prices and rising ROIs, including 2031 avg $2.06 (36.1%), 2032 avg $3.05 (101.7%), 2033 avg $3.37 (122.9%), 2040 avg $6.85 (353.4%), and 2050 avg $8.80 (482.6%).
A major floor 61.1% below — a decisive break under it would weaken the trend.
The nearest floor, 16.1% below — buyers have tended to step in here.
The nearest ceiling, 28.9% above — a clean break opens room to run.
A major ceiling 49.2% above — clearing it would confirm fresh momentum.
Key GNTA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GNTA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.49 | Sell | $1.50 | Sell |
| MA 10 | $1.56 | Sell | $1.52 | Sell |
| MA 20 | $1.53 | Sell | $1.55 | Sell |
| MA 50 | $1.56 | Sell | $1.47 | Buy |
| MA 100 | $1.13 | Buy | $1.38 | Buy |
| MA 200 | $1.42 | Buy | $1.65 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.65 | Neutral |
| Stoch RSI (14) | 62.84 | Neutral |
| CCI (20) | -27.23 | Neutral |
| Williams %R (14) | -40.00 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -0.67 | Sell |
| Bollinger %B (20,2) | 0.42 | Neutral |
| Stochastic %K (14) | 60.00 | Neutral |
| TRIX (15) | -0.10 | Sell |
| Awesome (5,34) | -0.15 | Sell |
| Ultimate (7,14,28) | 43.36 | Neutral |
| Momentum (10) | -0.06 | Sell |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 1.41 | Buy |
| ADX (14) | 11.06 | Neutral |
| ATR (14) | 0.09 | Info |
The 30-day technical picture is bullish, with RSI14 at 50 and near-term momentum supported by the moving averages. SMA50 is $1.54 and SMA200 is $1.43, placing price action near key levels of support and resistance. The explicit near-term range spans from a low of $0.9441 to a high of $2.42, with support at $1.25 and resistance at $1.92.
Annualized volatility sits at 100%, underscoring notable price variability within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.58 | $1.49 | $1.83 | 0% | Neutral | |
| $1.14 | $1.57 | $2.33 | +5% | Neutral | |
| $1.13 | $1.64 | $2.60 | +10% | Neutral | |
| $1.05 | $1.62 | $2.69 | +8% | Neutral | |
| $0.9857 | $1.59 | $2.75 | +7% | Neutral | |
| $1.12 | $1.89 | $3.39 | +27% | Bullish | |
| $1.60 | $2.82 | $5.22 | +89% | Bullish | |
| $1.69 | $3.10 | $5.89 | +108% | Bullish | |
| $1.66 | $3.17 | $6.18 | +113% | Bullish | |
| $1.69 | $3.36 | $6.69 | +125% | Bullish | |
| $2.76 | $6.14 | $13.47 | +312% | Bullish | |
| $3.55 | $7.89 | $18.15 | +430% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.58 | $1.49 | $1.85 | +0.00% |
| September 2026 | $1.16 | $1.41 | $1.79 | -5.21% |
| October 2026 | $1.14 | $1.41 | $1.83 | -0.20% |
| November 2026 | $1.15 | $1.44 | $1.89 | +2.10% |
| December 2026 | $1.09 | $1.37 | $1.83 | -4.98% |
Click any year to see its month-by-month GNTA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The GNTA price prediction for 2026 points to an average of $1.49 (low $0.58, high $1.83) — a potential gain of 0% on today's $1.49. A consolidation phase looks the most probable path here.
In 2027, GNTA is projected to trade between $1.14 and $2.33, averaging $1.57 — a potential gain of +5% from today's $1.49. That is up +5% on the projected 2026 average. Price action looks broadly range-bound.
Genenta Science S.p.A.'s 2028 outlook centres on $1.64, within a $1.13 to $2.60 range. That is up +5% on the projected 2027 average. That marks a +10% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, GNTA could reach as high as $2.69, with a base case around $1.62 and support toward $1.05 — roughly +8% from $1.49. Price action looks broadly range-bound.
Expect GNTA to range from $0.9857 to $2.75 through 2030. The $1.59 average target implies a +7% move from current prices. That is -2% versus the projected 2029 average. A consolidation phase looks the most probable path here.
The GNTA price prediction for 2031 points to an average of $1.89 (low $1.12, high $3.39) — a potential gain of +27% on today's $1.49. Momentum favours further upside here.
In 2032, GNTA is projected to trade between $1.60 and $5.22, averaging $2.82 — a potential gain of +89% from today's $1.49. That is up +49% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Genenta Science S.p.A.'s 2033 outlook centres on $3.10, within a $1.69 to $5.89 range. That is up +10% on the projected 2032 average. That marks a +108% change versus current levels. Momentum favours further upside here.
By 2034, GNTA could reach as high as $6.18, with a base case around $3.17 and support toward $1.66 — roughly +113% from $1.49. Buyers look set to stay in control over this stretch.
Expect GNTA to range from $1.69 to $6.69 through 2035. The $3.36 average target implies a +125% move from current prices. That is up +6% on the projected 2034 average. Momentum favours further upside here.
The GNTA price prediction for 2040 points to an average of $6.14 (low $2.76, high $13.47) — a potential gain of +312% on today's $1.49. Buyers look set to stay in control over this stretch.
In 2050, GNTA is projected to trade between $3.55 and $18.15, averaging $7.89 — a potential gain of +430% from today's $1.49. That is up +28% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in GNTA today (≈ 671.14094 GNTA) could be worth
$5,295.77
+$4,295.77 (+430%) by 2050 · US Dollar
Based on the average projected GNTA price of $7.89 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GNTAwould be worth at today's price.
$1,000 invested in GNTA on Jul 31, 2025 (≈ 260.010403 GNTA) would be worth
$387.42
-$612.58 (-61.3%) today · 0.39× · US Dollar
Based on a GNTA entry price of $3.85 vs. today's $1.49.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.59 | $937.11 | -6.3% |
| 1 month ago | $1.75 | $851.43 | -14.9% |
| 3 months ago | $0.73 | $2,041.1 | +104.1% |
| 6 months ago | $0.985 | $1,512.69 | +51.3% |
| 1 year ago | $3.85 | $387.42 | -61.3% |
| All time (4.6y) ago | $11 | $135.45 | -86.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GNTA forecast.
Our base-case forecast reaches $3.00 around 2033.
Implied market cap at $3.00: $144.65M
The multi-year forecast shows a path toward higher prices beginning in 2031, with 2031 avg $2.06 and 2032 avg $3.05, followed by continued gains through 2033 ($3.37), 2034 ($3.43), and 2035 ($3.63). By 2040 the average price is forecast at $6.85 and by 2050 at $8.80, with ROIs of 353.4% and 482.6% respectively, signaling substantial potential upside in the outer horizon. The outlook turns bullish in the later years, contrasting with the 2026 baseline where the sentiment is neutral and the 2027-2030 window features more modest gains.
These figures illustrate an expanded price path but remain estimates and not guarantees, subject to the usual investment uncertainties.
Tap a question to reveal the answer.
2030 min $1.05, avg $1.69, max $2.93; ROI 12.1%; sentiment NEUTRAL.
Near term shows a neutral outlook in 2026 with avg $1.51, while longer term from 2031 onward carries bullish sentiment and upside, with ROIs up to 482.6% by 2050.
Yes. The forecast indicates 2032 max $5.63 and 2033 max $6.40, implying a path to surpass $5 in those years.
Low $0.9441, High $2.42.
Current price $1.51; Market cap $72.81M.
Genenta Science S.p.A. Community Discussion
0Share your Genenta Science S.p.A. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.